Trials / Sponsors / TC Biopharm
TC Biopharm
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2025-01-01 |
| Terminated | ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lympho Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | 2022-08-15 |
| Withdrawn | A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19 COVID - 19 | Phase 2 | 2021-12-13 |
| Completed | Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML) Acute Myeloid Leukemia | Phase 1 | 2018-11-27 |
| Terminated | ImmuniCell® in Patients With Advanced Cancers Malignant Melanoma, Non-small Cell Lung Cancer, Renal Cell Cancer | Phase 2 | 2015-12-01 |